Reduction of PDK1 protein expression by ciglitazone was also found in other NSCLC cell lines (Figure 1D).We then tested whether the effects of ciglitazone on PDK1 were mediated through the activation of PPARγ. This evidence concerns the gene PPARG and non-small cell lung carcinoma.